All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Formulary
Back
Contact us about this page
Chapter 6: Endocrine
Toggle Parent Pages
Print this page
Type 2 diabetes mellitus treatment guidance
Management of thyroid disorders
Management of osteoporosis
Guidance on the management of menopause
Gender dysphoria and transgender prescribing
6.1 Drugs used in diabetes
6.2 Thyroid and antithyroid drugs
6.3 Corticosteroids
6.4 Sex hormones
6.5 Hypothalamic and pituitary hormones and anti-oestrogens
6.6 Drugs affecting bone metabolism
6.7 Other endocrine drugs
Page last updated:
1 June 2020
Contact us about this page
6.7.2 Drugs affecting gonadotrophins
First Line
Second Line
Specialist
Hospital Only
Danazol
- Danazol 100mg and 200mg capsules have been discontinued in the UK and remaining supplies of both strengths are now exhausted (DHSC, 29 May 2020)
- Clinicians should not initiate new patients on danazol 100mg and 200mg capsules
- GPs should identify all patients receiving danazol and contact the patient's specialist for advice on managing their care
- For more information, please see the ICB's Medicines Optimisation Post Live here
Gonadorelin analogues
Triptorelin
- See section 8.3.4 Hormone antagonists
Goserelin
- See section 8.3.4 Hormone antagonists
